• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对脑膜炎球菌重组外膜蛋白的杀菌抗体反应。

Bactericidal Antibody Responses to Meningococcal Recombinant Outer Membrane Proteins.

机构信息

Department of Pediatrics, Shandong Provincial Third Hospital, Shandong University, No.11 Wuyingshan, Middle Road, Tianqiao District, Jinan, Shandong 250031, P.R. China.

出版信息

J Microbiol Biotechnol. 2024 Jul 28;34(7):1419-1424. doi: 10.4014/jmb.2401.01018. Epub 2024 Apr 24.

DOI:10.4014/jmb.2401.01018
PMID:38955797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11294639/
Abstract

Secretin PilQ is an antigenically conserved outer membrane protein that is present in most meningococci and PorA is a major protein that elicits bactericidal immune response in humans following natural disease and immunization. In the present study, BALB/c mice were immunized subcutaneously with rPilQ406-770 or rPorA together with Freund's adjuvant (FA). Serum antibody responses to serogroup A and B whole cells or purified proteins and functional activity of antibodies were determined by ELISA and serum bactericidal assay (SBA), respectively. Serum IgG responses were significantly increased in the immunized group with rPilQ406-770 or rPorA together with FA compared to control groups. IgG antibody response of mice immunized with rPilQ406-770 was significantly more than mice immunized with rPorA (OD at 450 nm was 1.6 versus 0.83). The booster injections were effective in increasing the responses of anti-rPilQ406-770 or anti-rPorA IgG significantly. Antisera produced against rPilQ406-770 or rPorA demonstrated strong surface reactivity to serogroup B in comparison with control groups. Antisera raised against rPorA or rPilQ406-770 and FA demonstrated SBA titers from 1/1024 to 1/2048 against serogroup B. The strongest bactericidal activity was detected in sera from mice immunized with rPilQ406-770 mixed with FA. These results suggest that rPilQ406-770 is a potential vaccine candidate for serogroup B N. .

摘要

分泌蛋白 PilQ 是一种抗原保守的外膜蛋白,存在于大多数脑膜炎奈瑟菌中,PorA 是一种主要蛋白,在自然感染和免疫接种后,能在人体中引发杀菌免疫反应。在本研究中,BALB/c 小鼠经皮下免疫 rPilQ406-770 或 rPorA 与福氏佐剂(FA)。通过 ELISA 和血清杀菌试验(SBA)分别测定针对血清 A 群和 B 群全细胞或纯化蛋白的血清抗体反应和抗体的功能活性。与对照组相比,rPilQ406-770 或 rPorA 与 FA 联合免疫组的血清 IgG 反应显著增加。rPilQ406-770 免疫小鼠的 IgG 抗体反应明显高于 rPorA 免疫小鼠(OD450nm 为 1.6 比 0.83)。加强注射能有效提高抗 rPilQ406-770 或抗 rPorA IgG 的反应。与对照组相比,针对 rPilQ406-770 或 rPorA 的抗血清显示出对血清 B 群更强的表面反应性。针对 rPorA 或 rPilQ406-770 和 FA 的抗血清对血清 B 群的 SBA 滴度为 1/1024 至 1/2048。在与 FA 混合免疫 rPilQ406-770 的小鼠血清中检测到最强的杀菌活性。这些结果表明 rPilQ406-770 是 B 群 N. 的潜在疫苗候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb5/11294639/fb9a46d22a1a/jmb-34-7-1419-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb5/11294639/50b5042f68ff/jmb-34-7-1419-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb5/11294639/73e7875da3fc/jmb-34-7-1419-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb5/11294639/fb9a46d22a1a/jmb-34-7-1419-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb5/11294639/50b5042f68ff/jmb-34-7-1419-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb5/11294639/73e7875da3fc/jmb-34-7-1419-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0fb5/11294639/fb9a46d22a1a/jmb-34-7-1419-f3.jpg

相似文献

1
Bactericidal Antibody Responses to Meningococcal Recombinant Outer Membrane Proteins.针对脑膜炎球菌重组外膜蛋白的杀菌抗体反应。
J Microbiol Biotechnol. 2024 Jul 28;34(7):1419-1424. doi: 10.4014/jmb.2401.01018. Epub 2024 Apr 24.
2
Recombinant outer membrane secretin PilQ(406-770) as a vaccine candidate for serogroup B Neisseria meningitidis.重组外膜分泌蛋白 PilQ(406-770)作为 B 群脑膜炎奈瑟菌疫苗候选物。
Vaccine. 2012 Feb 21;30(9):1710-4. doi: 10.1016/j.vaccine.2011.12.076. Epub 2012 Jan 9.
3
Evaluation of immunological responses to recombinant Porin A protein (rPoA) from native strains of Neisseria meningitidis serogroups A and B using OMV as an adjuvant in BALB/c mice.评价使用 OMV 作为佐剂的源自 A 群和 B 群脑膜炎奈瑟菌天然株的重组 Porin A 蛋白(rPoA)在 BALB/c 小鼠中的免疫应答。
Microb Pathog. 2017 Nov;112:209-214. doi: 10.1016/j.micpath.2017.09.038. Epub 2017 Sep 20.
4
A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.一种脑膜炎球菌外膜囊泡疫苗,过表达突变 FHbp,在婴儿恒河猴中引起的保护性抗体反应高于已许可的 B 型脑膜炎球菌疫苗。
mBio. 2019 Jun 18;10(3):e01231-19. doi: 10.1128/mBio.01231-19.
5
A Meningococcal Native Outer Membrane Vesicle Vaccine With Attenuated Endotoxin and Overexpressed Factor H Binding Protein Elicits Gonococcal Bactericidal Antibodies.一种具有低内毒素和过表达因子 H 结合蛋白的脑膜炎奈瑟菌天然外膜囊泡疫苗可诱导淋病奈瑟菌杀菌抗体。
J Infect Dis. 2019 Mar 15;219(7):1130-1137. doi: 10.1093/infdis/jiy609.
6
The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate.脑膜炎奈瑟菌巨噬细胞感染增强蛋白诱导交叉株血清杀菌活性,是一种有潜力的 B 群疫苗候选物。
Infect Immun. 2011 Sep;79(9):3784-91. doi: 10.1128/IAI.05019-11. Epub 2011 Jun 27.
7
Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.抗A群脑膜炎奈瑟菌外膜囊泡疫苗的研发与特性分析
Vaccine. 2005 May 31;23(29):3762-74. doi: 10.1016/j.vaccine.2005.02.021. Epub 2005 Mar 14.
8
Sequential immunization with vesicles prepared from heterologous Neisseria meningitidis strains elicits broadly protective serum antibodies to group B strains.用源自异源脑膜炎奈瑟菌菌株制备的囊泡进行序贯免疫可引发针对B群菌株的广泛保护性血清抗体。
Infect Immun. 2002 Nov;70(11):6021-31. doi: 10.1128/IAI.70.11.6021-6031.2002.
9
Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.脑膜炎奈瑟菌纯化外膜蛋白复合物诱导免疫应答。
Vaccine. 2012 Mar 16;30(13):2387-95. doi: 10.1016/j.vaccine.2011.08.123. Epub 2011 Sep 10.
10
Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.从X群脑膜炎奈瑟菌中提取的外膜囊泡用于预防非洲的脑膜炎球菌病。
Pharmacol Res. 2017 Jul;121:194-201. doi: 10.1016/j.phrs.2017.04.030. Epub 2017 May 8.

本文引用的文献

1
Recent advances in non-small cell lung cancer targeted therapy; an update review.非小细胞肺癌靶向治疗的最新进展;综述更新
Cancer Cell Int. 2023 Aug 11;23(1):162. doi: 10.1186/s12935-023-02990-y.
2
Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation.基于间充质干细胞的治疗作为一种治疗急性炎症的新方法。
Life Sci. 2023 Jan 1;312:121206. doi: 10.1016/j.lfs.2022.121206. Epub 2022 Nov 18.
3
Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation.
间充质干细胞来源的外泌体对脂多糖诱导的全身炎症小鼠模型的免疫调节作用研究。
Life Sci. 2022 Dec 1;310:120938. doi: 10.1016/j.lfs.2022.120938. Epub 2022 Sep 20.
4
IL-38 as an early predictor of the ischemic stroke prognosis.IL-38 作为缺血性脑卒中预后的早期预测指标。
Cytokine. 2021 Oct;146:155626. doi: 10.1016/j.cyto.2021.155626. Epub 2021 Jun 19.
5
E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.E3 泛素连接酶 Casitas B 细胞淋巴瘤-b 及其在免疫治疗中的潜在治疗意义。
Clin Exp Immunol. 2021 Apr;204(1):14-31. doi: 10.1111/cei.13560. Epub 2021 Jan 10.
6
Cloning, expression and purification of outer membrane protein PorA of Neisseria meningitidis serogroup B.B群脑膜炎奈瑟菌外膜蛋白PorA的克隆、表达及纯化
J Infect Dev Ctries. 2011 Dec 13;5(12):856-62. doi: 10.3855/jidc.1557.
7
Potential of recombinant opa proteins as vaccine candidates against hyperinvasive meningococci.重组 Opa 蛋白作为针对高侵袭性脑膜炎奈瑟菌疫苗候选物的潜力。
Infect Immun. 2011 Jul;79(7):2810-8. doi: 10.1128/IAI.01338-10. Epub 2011 Apr 4.
8
Meningococcal protein antigens and vaccines.脑膜炎球菌蛋白抗原与疫苗
Vaccine. 2009 Jun 24;27 Suppl 2:B42-50. doi: 10.1016/j.vaccine.2009.05.001. Epub 2009 May 28.
9
Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.用表达脑膜炎奈瑟菌NadA的重组戈登链球菌对小鼠进行鼻内免疫可诱导全身性杀菌抗体和局部IgA。
Vaccine. 2008 Aug 5;26(33):4244-50. doi: 10.1016/j.vaccine.2008.05.049. Epub 2008 Jun 6.
10
Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency.血清杀菌性抗体对脑膜炎球菌多糖疫苗接种的反应作为常见可变免疫缺陷临床分类的基础。
Clin Vaccine Immunol. 2008 Apr;15(4):607-11. doi: 10.1128/CVI.00489-07. Epub 2008 Jan 30.